Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
BRD4 regulates PAI-1 expression in tumor-associated macrophages to drive chemoresistance in colorectal cancer
10.1124/dmd.113.055970 123 MinH
Various in vitro and clinical studies support the idea that berberine maintains blood glucose levels by promoting GLP-1 secretion
Investors excitement about the huge potential of novel AOMs propelled the valuations of Novo Nordisk and Lilly to record levels in 2024, with Lillys market cap reaching an all-time high of $912Bn on 30th August, the closest any biopharma company has come to the exclusive $1-trillion valuation
It's worth noting that GLP-1 receptor agonists generally have similar gastrointestinal side-effect profiles, though individual tolerance can vary between agents
US$ 22.44
US$ 24.02
US$ 28.12
